Literature DB >> 3678976

Incidence of ovarian metastasis in patients with cancer of the uterine cervix.

M Tabata1, K Ichinoe, N Sakuragi, Y Shiina, T Yamaguchi, Y Mabuchi.   

Abstract

During the period from 1970 to 1985, 706 patients with cervical cancer of stage 0 and Ia were treated by a simple hysterectomy without oophorectomy. In 326 patients with invasive carcinoma in stage Ib to stage III, who were treated by a radical hysterectomy from 1977 to 1985, histological examinations were performed to detect ovarian metastasis. A total of 674 autopsy specimens were obtained from the Annual of the Pathological Autopsy Cases in Japan. (Japanese Pathological Society, 1965 to 1978). Follow-up observations on stage 0 and stage Ia revealed no recurrence in the ovaries. In invasive cases of epidermoid carcinoma (stage Ib to stage III), no ovarian metastases were detected, despite discovery of metastases to the pelvic lymph node in 21.6% of the cases. Conversely, in the cases of cervical adenocarcinoma (pure adenocarcinoma and mixed carcinoma), 6 of 48 cases (12.5%) showed ovarian metastases. Ovarian metastases were found in 22 of 77 (28.6%) autopsy cases of adenocarcinoma, but in only 104 of 597 (17.4%) cases of epidermoid carcinoma. This finding is statistically significant (P less than 0.02). Both corpus invasion and metastasis to the ovaries were found in 20 of 54 cases (37.0%). This rate was significantly higher than the rate of ovarian metastasis in cases without corpus invasion (P less than 0.001).

Entities:  

Mesh:

Year:  1987        PMID: 3678976     DOI: 10.1016/0090-8258(87)90170-3

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  19 in total

1.  Ovarian recurrence from a Stage 1b1 cervical adenocarcinoma previously treated with radical vaginal trachelectomy: A case report.

Authors:  E C Brockbank; J Evans; N Singh; J H Shepherd; A R Jeyarajah
Journal:  Gynecol Oncol Case Rep       Date:  2012-01-16

2.  Oral metastases from carcinoma of cervix.

Authors:  Hari Ram; Manoj Kumar; M L B Bhatt; Mohammad Shadab
Journal:  BMJ Case Rep       Date:  2013-06-14

3.  Significance of uterine corpus tumor invasion in early-stage cervical cancer.

Authors:  K Matsuo; H Machida; E A Blake; T Takiuchi; M Mikami; L D Roman
Journal:  Eur J Surg Oncol       Date:  2017-02-03       Impact factor: 4.424

4.  A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.

Authors:  Xiuzhen Xie; Kun Song; Baoxia Cui; Jie Jiang; Xingsheng Yang; Beihua Kong
Journal:  Int J Clin Oncol       Date:  2018-01-03       Impact factor: 3.402

5.  Secondary Involvement of the Adnexa and Uterine Corpus by Carcinomas of the Uterine Cervix: A Detailed Morphologic Description.

Authors:  Carolina Reyes; Rajmohan Murali; Kay J Park
Journal:  Int J Gynecol Pathol       Date:  2015-11       Impact factor: 2.762

6.  Clinical, Morphologic, and Molecular Features Associated With Ovarian Metastases From Pattern A Endocervical Adenocarcinomas.

Authors:  Jacqueline Feinberg; Anjelica Hodgson; Nadeem R Abu-Rustum; Kara Long Roche; Kay J Park
Journal:  Am J Surg Pathol       Date:  2022-04-01       Impact factor: 6.394

Review 7.  Conservative Surgery for Early Cervical Cancer.

Authors:  P Rema; Iqbal Ahmed
Journal:  Indian J Surg Oncol       Date:  2015-10-21

8.  Uterine corpus involvement as well as histologic type is an independent predictor of ovarian metastasis in uterine cervical cancer.

Authors:  Min-Jeong Kim; Hyun Hoon Chung; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

9.  Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?

Authors:  Huaiwu Lu; Jing Li; Lijuan Wang; Hui Zhou; Yunyun Liu; Dongyan Wang; Zhongqiu Lin
Journal:  Med Sci Monit       Date:  2016-02-08

10.  Bilateral ovarian metastatic squamous cell carcinoma arising from the uterine cervix and eluding the Mullerian mucosa.

Authors:  Sunil Jaiman; Kameswari Surampudi; Sirisha Rao Gundabattula; Deepasha Garg
Journal:  Diagn Pathol       Date:  2014-06-04       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.